Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS
Vancomycin, a glycopeptide antibiotic used to treat severe Gram-positive bacterial infections, is associated with the development of drug reaction with eosinophilia and systemic symptoms (DRESS) in individuals expressing HLA-A*32:01. Previous studies have identified the potential role of T-cells using HLA-A*32:01-positive healthy donor models. However, DRESS pathogenesis remains poorly defined, and a deeper mechanistic understanding is required to aid the diagnosis and prediction of vancomycin-induced DRESS. The present study aims to elucidate CD4+ and CD8+ T-cell involvement within the pathogenesis of vancomycin-induced DRESS following the isolation and functional study of cloned T-cells from hypersensitive patients. CD4+ and CD8+ vancomycin-responsive T-cell clones (TCCs) were generated by serial dilution from peripheral blood mononuclear cells collected from suspected vancomycin-DRESS patients. Functionality of drug-responsive TCCs was assessed using T-cell proliferation ([3H]-thymidine). Cytokine analysis was performed using intracellular cytokine staining, enzyme-linked immunospot assay, and LEGENDplex immunoassays. Vancomycin-responsive TCCs expressing CD4+ and CD8+ phenotypes were successfully generated from suspected vancomycin-DRESS patients (n = 3). CD45RO+ memory T-cells were the primary activated population, with both CD4+ and CD8+ T-cells associated with the release of IFN-γ, IL-5, IL-13, granzyme B, and perforin. Vancomycin-responsive CD4+ and CD8+ T-cells are activated by direct, pharmacological interactions, with antigen presentation possible through HLA class I and HLA class II molecules. This study provides in vitro evidence for the dual role of antigen-specific CD4+ and CD8+ T-cells within the pathogenesis of vancomycin-induced DRESS. This has been demonstrated following the generation of cloned T-cells with strong vancomycin specificity from patients presenting with vancomycin-DRESS and positive for expression of HLA-A*32:01.
Authors
- James Line (ORCID: https://orcid.org/0000-0003-3568-8928)
- Andrew Gibson (ORCID: https://orcid.org/0000-0001-9653-3298)
- Michael R. Ardern‐Jones (ORCID: https://orcid.org/0000-0003-1466-2016)
- Silvia Martinez-Rivera (ORCID: https://orcid.org/0009-0004-1988-4544)
- Dean John Naisbitt (ORCID: https://orcid.org/0000-0003-4107-7832)
- Joshua Gardner (ORCID: https://orcid.org/0000-0002-4520-108X)
- Paul Thomson (ORCID: https://orcid.org/0000-0001-5431-0459)
- Matthew S. Krantz (ORCID: https://orcid.org/0000-0001-7589-9127)
- Elizabeth Jane Phillips (ORCID: https://orcid.org/0000-0002-7623-3383)
- Elsie Clarke (ORCID: https://orcid.org/0000-0002-5913-0606)
Institutions
- University of Liverpool (GB)
- Murdoch University (AU)
- Vanderbilt University (US)
- Southampton General Hospital (GB)
- Toulouse Mathematics Institute (FR)
- Vanderbilt Health (US)
Publication Details
- Journal
- Toxicological Sciences
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1093/toxsci/kfaf074
- Citations
- 2
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.79